A reassortment vaccine candidate as the improved formulation to induce protection against very virulent infectious bursal disease virus

Vaccine

Volumn 32, Issue 13, 2014, Pages 1436-1443

  Qi, Xiaole ^a   Chen, Yuming ^a   Ren, Xiangang ^a   Zhang, Lizhou ^a   Gao, Li ^a   Wang, Nian ^a   Qin, Liting ^a   Wang, Yongqiang ^a   Gao, Yulong ^a   Wang, Xiaomei ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Infectious bursal disease virus (IBDV); Reassortment; Reverse genetics; Vaccine

Indexed keywords

INFECTIOUS BURSAL DISEASE VIRUS VACCINE; LIVE VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG FORMULATION; HUMORAL IMMUNITY; IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; INFECTIOUS BURSAL DISEASE VIRUS; NONHUMAN; PRIORITY JOURNAL; REVERSE GENETICS; SYSTEMATIC REVIEW; VIRUS STRAIN;

INFECTIOUS BURSAL DISEASE VIRUS (IBDV); REASSORTMENT; REVERSE GENETICS; VACCINE;

ANIMALS; ANTIBODIES, VIRAL; BIRNAVIRIDAE INFECTIONS; CHICKENS; HEMAGGLUTINATION INHIBITION TESTS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; INFECTIOUS BURSAL DISEASE VIRUS; MUTAGENESIS, SITE-DIRECTED; POULTRY DISEASES; REASSORTANT VIRUSES; REVERSE GENETICS; VACCINES, ATTENUATED; VIRAL VACCINES; VIRUS REPLICATION;

EID: 84896720057     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.01.042     Document Type: Article

References (67)

1. Cosgrove A.S. An apparently new disease of chickens: avian nephrosis. Avian Dis 1962, 6:385-389.
2. Müller H., Islam M.R., Raue R. Research on infectious bursal disease-the past, the present and the future. Vet Microbiol 2003, 97:153-165.
3. Mundt E., Beyer J., Müller H. Identification of a novel viral protein in infectious bursal disease virus infected cells. J Gen Virol 1995, 76:437-443.
4. Azad A.A., Jagadish M.N., Brown M.A., Hudson P.J. Deletion mapping and expression in Escherichia coli of the large genomic segment of a birnavirus. Virology 1987, 161:145-152.
5. Jagadish M.N., Staton V.J., Hudson P.J., Azad A.A. Birnavirus precursor polyprotein is processed in Escherichia coli by its own virus encoded polypeptide. J Virol 1988, 62:1084-1087.
6. Coulibaly F., Chevalier C., Gutsche I., Pous J., Navaza J., Bressanelli S., et al. The birnavirus crystal structure reveals structural relationships among icosahedral viruses. Cell 2005, 120:761-772.
7. Saugar I., Luque D., Ona A., Rodriguez J.F., Carrascosa J.L., Trus B.L., et al. Structural polymorphism of the major capsid protein of a double-stranded RNA virus: an amphipathic alpha helix as a molecular switch. Structure 2005, 13:1007-1017.
8. Boot H.J., Ter Huume A.H.M., Hoekman A.J.W., Peeters B.P.H., Gielkens A.L.J. Rescue of very virulent and mosaic infectious bursal disease virus from cloned cDNA: VP2 is not the sole determinant of the very virulent phenotype. J Virol 2000, 74:6701-6711.
9. Brandt M., Yao K., Liu M., Hackert R.A., Vakharia N.V. Molecular determinants of virulence, cell tropism, and pathogenic phenotype of infectious bursal disease virus. J Virol 2001, 75:11974-11982.
10. Jackwood D.J., Sreedevi B., LeFever L.J., Sommer-Wagner S.E. Studies on naturally occurring infectious bursal disease viruses suggest that a single amino acid substitution at position 253 in VP2 increases pathogenicity. Virology 2008, 377:110-116.
11. Lim B.L., Cao Y.C., Yu T., Mo C.W. Adaption of very virulent infectious bursal disease virus to chicken embryonic fibroblasts by site-directed mutagenesis of residues 279 and 284 of viral coat protein VP2. J Virol 1999, 73:2854-2862.
12. Mundt E. Tissue culture infectivity of different strains of infectious bursal disease virus is determination by distinct amino acids in VP2. J Gen Virol 1999, 80:2067-2076.
13. Qi X., Gao H., Gao Y., Qin L., Wang Y., Gao L., et al. Naturally occurring mutations at residues 253 and 284 in VP2 contribute to the cell tropism and virulence of very virulent infectious bursal disease. Antiviral Res 2009, 84:225-233.
14. Van Loon A.A., de Haas N., Zeyda I., Mundt E. Alteration of amino acids in VP2 of very virulent infectious bursal disease virus results in tissue culture adaptation and attenuation in chickens. J Gen Virol 2002, 83:121-129.
15. Durairaj V., Sellers H.S., Linnemann E.G., Icard A.H., Mundt E. Investigation of the antigenic evolution of field isolates using the reverse genetics system of infectious bursal disease virus (IBDV). Arch Virol 2011, 56:1717-1728.
16. Icard A.H., Sellers H.S., Mundt E. Detection of infectious bursal disease virus isolates with unknown antigenic properties by reverse genetics. Avian Dis 2008, 52:590-598.
17. Letzel T., Coulibaly F., Rey F.A., Delmas B., Jagt E., van Loon A.A., et al. Molecular and structural bases for the antigenicity of VP2 of infectious bursal disease virus. J Virol 2007, 81:12827-12835.
18. Luque D., Saugar I., Rejas M.T., Carrascosa J.L., Rodriguez J.F., Castón J.R. Infectious bursal disease virus: ribonucleoprotein complexes of a double-stranded RNA virus. J Mol Biol 2009, 386:891-901.
19. Luque D., Saugar I., Rodriguez J.F., Verdaguer N., Garriga D., Martin C.S., et al. Infectious bursal disease virus capsid assembly and maturation by structural rearrangements of a transient molecular switch. J Virol 2007, 81:6869-6878.
20. Birghan C., Mundt E., Gorbalenya A. A non-canonical lon proteinase lacking the ATPase domain employs the Ser-Lys catalytic dyad to exercise broad control over the life cycle of a double-stranded RNA virus. EMBO J 2000, 19:114-123.
21. Feldman A.R., Lee J., Delmas B., Paetzel M. Crystal structure of a novel viral protease with a serine/lysine catalytic dyad mechanism. J Mol Biol 2006, 358:1378-1389.
22. Lejal N., Da Costa B., Huet J.C., Delmas B. Role of Ser-652 and lys-692 in the protease activity of infectious bursal disease virus VP4 and identification of its substrate cleavage sites. J Gen Virol 2000, 81:983-992.
23. Le Nouen C., Rivallan G., Toquin D., Darlu P., Morin Y., Beven V., et al. Very virulent infectious bursal disease virus: reduced pathogenicity in a rare natural segment-B-reassorted isolate. J Gen Virol 2006, 87:209-216.
24. Von Einem U.I., Gorbalenya A.E., Schirrmeier H., Behrens S.E., Letzel T., Mundt E. VP1 of infectious bursal disease virus is an RNA-dependent RNA polymerase. J Gen Virol 2004, 85:2221-2229.
25. Müller H., Mundt E., Eterradossi N., Islam R. Current status of vaccines against infectious bursal disease. Avian Pathol 2012, 41:133-139.
26. Jackwood D.H., Saif Y.M. Antigenic diversity of infectious bursal disease viruses. Avian Dis 1987, 31:766-770.
27. Chettle N., Stuart J.C., Wyeth P.J. Outbreak of virulent infectious bursal disease in East Anglia. Vet Rec 1989, 125:271-272.
28. Wang X., Zeng X., Gao H., Fu C., Wei P. Changes in VP2 gene during the attenuation of very virulent infectious bursal disease virus strain Gx isolated in China. Avian Dis 2004, 48:77-83.
29. Yamaguchi T., Ogawa M., Inoshima Y., Miyoshi M., Fukushi H., Hirai K. Identification of sequence changes responsible for the attenuation of highly virulent infectious bursal disease virus. Virology 1996, 223:219-223.
30. Jackwood D.J. Molecular epidemiologic evidence of homologous recombination in infectious bursal disease viruses. Avian Dis 2012, 56:574-577.
31. Jackwood D.J., Stoute S.T. Molecular evidence for a geographically restricted population of infectious bursal disease viruses. Avian Dis 2013, 57:57-64.
32. Qi X., Gao L., Qin L., Deng X., Wu G., Zhang L., et al. Genomic sequencing and characterization of a very virulent strain of infectious bursal disease virus isolated in China. Agric Sci Technol 2011, 12:1950-1953.
33. Mundt E., de Haas N., van Loon A. Development of a vaccine for immunization against classical as well as variant strains of infectious bursal disease virus using reverse genetics. Vaccine 2003, 41:4616-4624.
34. Gao L., Qi X., Gao H., Gao Y., Qin L., Wang Y., et al. Development of a tailored vaccine against very virulent infectious bursal disease virus (vvIBDV) of chickens using reverse genetics. Vaccine 2011, 26:5550-5557.
35. Qi X., Gao Y., Gao H., Deng X., Bu Z., Wang X., et al. An improved method for infectious bursal disease virus rescue using RNA polymerase II system. J Virol Methods 2007, 142:81-88.
36. Wang X., Fu C., Gao H., Song X., Zeng X., Zhang M., et al. Pathogenic antigenic and molecular characterization of very virulent strain (Gx) of infectious bursal disease virus isolated in China. Agric Sci China 2003, 2:566-572.
37. Lucio B., Hitchner S.B. Infectious bursal disease emulsified vaccine: effect upon neutralizing antibody levels in the dam and subsequent protection of the progeny. Avian Dis 1979, 23:466-478.
38. Wang Y., Qi X., Gao H., Gao Y., Lin H., Song X., et al. Comparative study of the replication of IBDV in DF1 cell line and CEF evaluated by new real-time RT-PCR. J Virol Methods 2009, 157:205-210.
39. OIE (World Organisation for Animal Health) Manual of diagnostic tests and vaccines for terrestrial animals. Chapter 2.3.4. Avian influenza 2009, World Organisation for Animal Health, Paris, France.
40. Mahgoub H.A. An overview of infectious bursal disease. Arch Virol 2012, 157:2047-2057.
41. Yuwen Y., Gao Y., Gao H., Qi X., Liu W., Wang X. Sequence analysis of the VP2 hypervariable region of eight very virulent infectious bursal disease virus isolates from the northeast of China. Avian Dis 2008, 52:284-290.
42. Eterradossi N., Arnauld C., Toquin D., Rivallan G. Critical amino acid changes in VP2 variable domain are associated with typical and atypical antigenicity in very virulent infectious bursal disease viruses. Arch Virol 1998, 143:1627-1636.
43. Vakharia V.N., He J., Ahamed B., Snyder D.B. Molecular basis of antigenic variation in infectious bursal disease virus. Virus Res 1994, 31:265-273.
44. Jackwood D.J., Sommer-Wagner S.E., Crossley B.M., Stoute S.T., Woolcock P.R., Charlton B.R. Identification and pathogenicity of a natural reassortant between a very virulent serotype 1 infectious bursal disease virus (IBDV) and a serotype 2 IBDV. Virology 2011, 420:98-105.
45. Fahey K.J., Erny K., Crooks J. A conformational immunogen on VP2 of infectious bursal disease virus that induces virus neutralizing antibodies that passively protect chickens. J Gen Virol 1989, 70:1473-1481.
46. Müller H., Schnitzler D., Bernstein F., Becht H., Cornelissen D., Lutticken D.H. Infectious bursal disease of poultry: antigenic structure of the virus and control. Vet Microbiol 1992, 33:175-183.
47. Wang Y., Qi X., Kang Z., Yu F., Qin L., Gao H., et al. A single amino acid in the C-terminus of VP3 protein influences the replication of attenuated infectious bursal disease virus in vitro and in vivo. Antiviral Res 2010, 87:223-229.
48. Li Z., Wang Y., Li X., Li X., Cao H., Zheng S.J. Critical roles of glucocorticoid-induced leucine zipper in infectious bursal disease virus (IBDV)-induced suppression of type I interferon expression and enhancement of IBDV growth in host cells via interaction with VP4. J Virol 2013, 87:1221-1231.
49. Li Z., Wang Y., Xue Y., Li X., Cao H., Zheng S.J. Critical role for voltage-dependent anion channel 2 in infectious bursal disease virus-induced apoptosis in host cells via interaction with VP5. J Virol 2012, 86:1328-1338.
50. Qin L., Qi X., Gao Y., Gao H., Lu X., Wang Y., et al. VP5-deficient mutant virus induced protection against challenge with very virulent infectious bursal disease virus of chickens. Vaccine 2010, 20:3735-3740.
51. Wei L., Hou L., Zhu S., Wang J., Zhou J., Liu J. Infectious bursal disease virus activates the phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway by interaction of VP5 protein with the p85α subunit of PI3K. Virology 2011, 417:211-220.
52. Yao K., Goodwin M.A., Vakharia V.N. Generation of mutant infectious bursal disease virus that does not cause bursal lesions. J Virol 1998, 72:2647-2654.
53. Boot H.J., Huurne A.A., Peeter B.P., Gielkens A.L. Efficient rescue of infectious bursal disease virus from cloned cDNA: evidence for involvement of the 3'-terminal sequence in genome replication. Virology 1999, 265:330-341.
54. Qi X., Zhang L., Chen Y., Gao L., Wu G., Qin L., et al. Mutations of residues 249 and 256 in VP2 are involved in the replication and virulence of infectious bursal disease virus. PLOS ONE 2013, 8:e70982.
55. Garriga D., Querol-Audi J., Abaitua F., Saugar I., Pous J., Verdaguer N., et al. The 2.6-Angstrom structure of infectious bursal disease virus-derived T=1 particles reveals new stabilizing elements of the virus capsid. J Virol 2006, 80:6895-6905.
56. Lee C.C., Ko T.P., Chou C.C., Yoshimura M., Doong S.R., Wang M.Y., et al. Crystal structure of infectious bursal disease virus VP2 subviral particle at 2.6Å resolution: implications in virion assembly and immunogenicity. J Struct Biol 2006, 155:74-86.
57. Escaffre O., Le Nouën C., Amelot M., Ambroggio X., Ogden K.M., Guionie O., et al. Both genome segments contribute to the pathogenicity of very virulent infectious bursal disease virus. J Virol 2013, 87:2767-2780.
58. Le Nouen C., Toquin D., Muller H., Raue R., Kean K.M., Langlois P., et al. Different domains of the RNA polymerase of infectious bursal disease virus contribute to virulence. PLoS ONE 2012, 7:e28064.
59. Wei Y., Li J., Zheng J., Xu H., Li L., Yu L. Genetic reassortment of infectious bursal disease virus in nature. Biochem Biophys Res Commun 2006, 350:277-287.
60. Wei Y., Yu X., Zheng J., Chu W., Xu H., Yu X., et al. Reassortant infectious bursal disease virus isolated in China. Virus Res 2008, 131:279-282.
61. Yu F., Ren X., Wang Y., Qi X., Song J., Gao Y., et al. A single amino acid substitution in VP1 attenuates virulence of vvIBDV in SPF chickens and increases replication in CEF cells. Virology 2013, 440:204-209.
62. Hon C., Lam T., Drummond A., Rambaut A., Lee Y.F., Yip C., et al. Phylogenetic analysis reveals a correlation between the expansion of very virulent infectious bursal disease virus and reassortment of its genome segment B. J Virol 2006, 80:8503-8509.
63. Yeh H.Y., Rautenschlein S., Sharma J.M. Protective immunity against infectious bursal disease virus in chickens in the absence of virus-specific antibodies. Vet Immunol Immunopathol 2002, 89:149-158.
64. Lambrecht B., Gonze M., Meulemans G., van den Berg T.P. Production of antibodies against chicken interferon-gamma: demonstration of neutralizing activity and development of a quantitative ELISA. Vet Immunol Immunopathol 2000, 74:137-144.
65. Vervelde L., Davison T.F. Comparison of the in situ changes in lymphoid cells during infection with infectious bursal disease virus in chickens of different ages. Avian Pathol 1997, 26:803-821.
66. Dijkmans R., Creemers J., Billiau A. Chicken macrophage activation by interferon: do birds lack the molecular homologue of mammalian interferon-gamma. Vet Immunol Immunopathol 1990, 26:319-332.
67. Müller H. Replication of infectious bursal disease virus in lymphoid cells. Arch Virol 1986, 87:191-203.